IBM Appoints Martin Schroeter To Lead Managed Infrastructure Services Business

IBM (IBM) has appointed Martin Schroeter as Chief Executive Officer of the independent company that will be created following the separation of the company's Managed Infrastructure Services business, effective January 15. Schroeter served as IBM's Senior Vice President, Global Markets. He was the company's CFO from 2014 to 2017.

Arvind Krishna, CEO of IBM, said: "Martin has a deep understanding of the industry and has earned the trust of our clients and of the investor community. He has the strategic vision and business judgement to realize NewCo's enormous potential as the global leader in managed infrastructure services."

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
IBSA Pharma Inc. is recalling 27 lots of TIROSINT-SOL (levothyroxine sodium) Oral Solution to the consumer level due to subpotency, the U.S. Food and Drug Administration said. TIROSINT-SOL is indicated for Hypothyroidism and Pituitary Thyrotropin (Thyroid-Stimulating Hormone, TSH) Suppression. Meanwhile, the recall does not apply to TIROSINT (levothyroxine sodium) capsules. The U.S. Food and Drug Administration approved GlaxoSmithKline LLC's Jesduvroq tablets (daprodustat) for anemia caused by chronic kidney disease or CKD for adults who have been receiving dialysis for at least four months. It is the first oral treatment for anemia, i.e., decreased number of red blood cells, in the given indication that has received FDA approval. German banking major Deutsche Bank AG reported Thursday a significantly higher profit in its fourth quarter and fiscal 2022, mainly reflecting a tax benefit in the U.S, despite weakness in Investment Bank and asset management revenues. The company said it recorded its highest annual profit, both before and after tax, since 2007. However, Deutsche Bank shares were losing around 4 percent...
Follow RTT